文献速递生殖医学

无干扰培养:该培养策略对胚胎体外发育和临床结局的临床检验

Undisturbed culture: a clinical examination of this culture strategy on embryo in vitro development and clinical outcomes.
PubMed 文献 · Fertil Steril · 2024-07-22

这项回顾性队列研究纳入5年间4564个ICSI周期,比较完全无干扰培养与序贯培养对胚胎体外发育和临床结局的影响。无干扰培养与自体周期和卵母细胞捐赠周期首次胚胎移植后活产率升高相关;卵母细胞捐赠周期的累积活产率及囊胚率、优质囊胚率和利用率也与无干扰培养正相关,但自体周期未见这些关联。

要点

  • 无干扰培养与自体周期首次移植活产率升高相关(OR 1.617,95%CI 1.074-2.435)。
  • 无干扰培养与卵母细胞捐赠周期首次移植活产率升高相关(OR 1.316,95%CI 1.036-1.672)。
  • 卵母细胞捐赠周期1年累积活产率与无干扰培养正相关(OR 1.5,95%CI 1.179-1.909),自体周期无此关联。

核心结论

  • 研究提示,整合时差成像培养箱与一步法培养液的培养系统可能通过增加高质量囊胚产出和改善胚胎选择,提高ICSI治疗患者的成功率,同时简化实验室流程。

研究设计与样本

  • 回顾性队列研究,纳入5年间4564个ICSI周期,包括自体与卵母细胞捐赠治疗,均进行延长的囊胚培养。
  • 采用广义估计方程量化培养策略对胚胎发育和临床结局的影响,并通过逆概率治疗加权法控制可能的混杂因素。

主要发现

  • 无干扰培养与自体周期首次胚胎移植后活产率升高相关(OR 1.617,95%CI 1.074-2.435)。
  • 无干扰培养与卵母细胞捐赠周期首次胚胎移植后活产率升高相关(OR 1.316,95%CI 1.036-1.672)。
  • 卵母细胞捐赠周期1年随访累积活产率与无干扰培养正相关(OR 1.5,95%CI 1.179-1.909),自体周期无此关联(OR 1.051,95%CI 0.777-1.423)。
  • 卵母细胞捐赠周期的囊胚率、优质形态囊胚率和利用率与无干扰培养正相关,自体周期未见这些关联。

关键数值与推荐

  • 主要结局指标为新鲜单胚胎移植后活产率和累积活产率的加权OR及95%CI。
  • 无干扰培养组与序贯培养组比较:自体周期首次移植活产率OR 1.617(95%CI 1.074-2.435);卵母细胞捐赠周期首次移植活产率OR 1.316(95%CI 1.036-1.672)。
  • 卵母细胞捐赠周期1年累积活产率OR 1.5(95%CI 1.179-1.909);自体周期累积活产率OR 1.051(95%CI 0.777-1.423)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the effect of a fully undisturbed culture strategy over a sequential one on embryo in vitro development and clinical outcomes in intracytoplasmic sperm injection (ICSI) cycles. DESIGN: Retrospective cohort study. SETTING: University-affiliated private IVF center. PATIENT(S): This study included 4,564 ICSI cycles performed over 5 years, including autologous and oocyte donation treatments with extended embryo culture until blastocyst in one of the two defined culture strategies. INTERVENTION(S): Embryo cohorts were cultured in one of two culture systems: a fully undisturbed culture, including an incubator with integrated time-lapse technology, a one-step culture medium and embryo selection assisted by semi-automatic tools on the basis of embryo morphokinetics, or a sequential culture, using a conventional benchtop incubator, sequential media and traditional morphological evaluation under optical microscope. The effect of the culture strategies on embryo development and clinical outcomes was quantified by generalized estimated equations, controlling for possible confounders through the inverse probability of the treatment weighting method. MAIN OUTCOME MEASURE(S): Weighted odds ratios (ORs) and 95% confidence intervals (CIs) for live birth rate after fresh single embryo transfer and the cumulative live birth rate. In addition, blastocyst development and morphology and other intermediate outcomes were also assessed. RESULT(S): A significant positive association was found between the employment of undisturbed embryo culture and higher live birth rate in the first embryo transfer in both autologous (OR, 1.617; 95% CI, 1.074-2.435) and oocyte donation cycles (OR, 1.316; 95% CI, 1.036-1.672). Cumulative live birth rate after 1-year follow-up was also positively associated with the undisturbed culture strategy in oocyte donation cycles (OR, 1.5; 95% CI, 1.179-1.909), but not in autologous cycles (OR, 1.051; 95% CI, 0.777-1.423). Similarly, blastocyst rate, good morphology blastocyst rate, and utilization rate were positively associated with the employment of undisturbed culture in oocyte donation cycles, but not in autologous cycles. CONCLUSION(S): These findings imply that a culture system combining integrated time-lapse incubators with a one-step culture medium may enhance the success rates of patients undergoing ICSI treatment by increasing the production of higher quality blastocysts and improving embryo selection while streamlining laboratory procedures and workflow.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Valera MÁ, Garg A, Bori L, et al. Undisturbed culture: a clinical examination of this culture strategy on embryo in vitro development and clinical outcomes. Fertil Steril. 2024. PMID: 39048020. doi:10.1016/j.fertnstert.2024.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。